News Focus
News Focus
Post# of 257253
Next 10
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 151640

Saturday, 11/03/2012 11:51:02 AM

Saturday, November 03, 2012 11:51:02 AM

Post# of 257253
Seems that Gilenya share comes a lot more at the expense of the beta interferon class than of Copaxone and Tysabri.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today